Craniofacial metastases: a 20-year survey.
Oliver C Thiele1, Kolja Freier, Claire Bacon
1Department of Oral and Maxillofacial Surgery, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany. oliver.thiele@med.uni-heidelberg.de
Summary
This study examined the prognosis for 52 patients with craniofacial metastases. Key factors influencing survival included metastasis type and primary tumor site, with an average survival of 14.4 months post-metastasis.
Area of Science:
- Oncology
- Head and Neck Surgery
- Medical Research
Background:
- Distant metastases to the craniofacial area are rare but significantly impact patient prognosis.
- Understanding predictive factors for survival in these patients is crucial for treatment planning.
Purpose of the Study:
- To analyze the long-term prognosis of patients with craniofacial metastases.
- To identify potential predictive factors influencing overall survival.
Main Methods:
- Retrospective analysis of 52 patients treated between 1989 and 2009.
- Evaluation of factors including age, gender, histopathology, metastasis location, and primary tumor characteristics.
Main Results:
- Average age was 63 years; 62% were male.
- Adenocarcinoma was the most common type; lung, skin melanoma, and breast were common primary sites.
- Average survival was 14.4 months post-metastasis and 43.4 months post-primary tumor.
Conclusions:
- Craniofacial metastases present a significant survival challenge.
- Identifying primary tumor and metastasis characteristics aids in predicting patient outcomes.
